As of 3:51pm ET
| -0.03 / -0.51%|
The 3 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +19.25% increase from the last price of 5.87.
The current consensus among 4 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.